In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study
Youn H. Kim(Stanford University), Ronald Levy(Hôpital Necker-Enfants Malades), Robert Tibshirani(Stanford University), Daniel Navi, Bharathi Lingala(Stanford University), Weiyun Z. Ai(City College of San Francisco), Ranjana H. Advani(Stanford Medicine), Leon Xing, Dita Gratzinger(Stanford University), Anjali V. Morales, Farah Abdulla(Caris Life Sciences (United States)), Richard T. Hoppe(Stanford Medicine), Sumit Shah(Palo Alto University), Cameron Harrison, Debra K. Czerwinski(Stanford University), Joshua Brody(New York University)
Cited by 213
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2013|1.7k